Gut microbes and metabolites may influence aging, though human evidence remains limited

Photo by National Institute of Allergy and Infectious Diseases / Unsplash

Frontiers in Medicine Published June 1, 2026 Medically reviewed June 1, 2026 DOI ↗ By Dr. Sofia Müller, MD · Lifespan & Whole-Person Care

Key Takeaway

Consider the potential of gut microbes in aging research, though human evidence is currently limited.

This narrative review explores the potential role of gut microbes and their metabolites, including short-chain fatty acids, bile acids, tryptophan derivatives, and polyamines, in the aging process. The scope of the article focuses on the theoretical connections between the microbiome and epigenetics rather than reporting specific clinical trial data or human outcomes. The authors highlight that little direct evidence exists in humans to support definitive clinical claims at this time.

Most of the current evidence originates from animal studies rather than direct tests in people. Consequently, the review emphasizes that the causal pathways between gut microbes and the body remain unclear as both systems change constantly over time. The authors aim to distinguish direct effects from indirect changes but note that cause and effect needs further determination via broad, long-term studies.

The practice relevance of this work lies in the potential for future applications. Understanding this system better could help create new biomarkers and treatments to influence aging by targeting the microbiome and its effects on epigenetics. However, clinicians should interpret these findings cautiously given the lack of human data and the reliance on preclinical models.

Study Details

Study typeSystematic review

EvidenceLevel 1

PublishedJun 2026

View Original Abstract ↓

Researchers now see aging as a process shaped by the interactions among metabolism, epigenetics, and hormones. Recent studies suggest that gut microbes play an important role in this system by making metabolites that can affect gene expression and chromatin structure. Still, it is not fully clear how gut microbes and the body influence each other as we age, since both are constantly changing. This review brings together current research on how metabolites from gut microbes—such as short-chain fatty acids, bile acids, tryptophan derivatives, and polyamines—affect the body’s epigenetic machinery through processes such as DNA methylation, histone modifications, and chromatin remodeling. We examine evidence from cell studies, animal experiments, and human research to assess the strength of the links and distinguish direct effects on chromatin from indirect metabolic or gene-expression changes. We focus especially on endocrine and reproductive organs, such as the hypothalamus, pancreas, liver, fat tissue, and cells that support the gonads, where signals from gut microbes overlap with hormonal control and metabolism. In these tissues, microbial metabolites influence key pathways related to inflammation, mitochondria, and nutrient sensing, but there is still little direct evidence in humans. The review also points out differences between lab models and what is observed in patients, highlighting the need for further work to apply these findings in real-world settings. Interactions between gut microbes and epigenetics form a two-way link between metabolism, immunity, and aging of the endocrine system. While more evidence shows that microbial metabolites can shape gene activity and epigenetic patterns, most of what we know comes from animal studies rather than direct tests in people. Moving forward, researchers will need to use broad, long-term studies that combine different types of data to figure out cause and effect and which tissues are involved. Understanding this system better could help create new biomarkers and treatments to influence aging by targeting the microbiome and its effects on epigenetics.